Form 4: ALX Oncology Holdings Inc. Interim CFO Sells Shares to Cover Tax Obligations

Shelly Pinto, Interim CFO of ALX Oncology Holdings Inc., sold 2,221 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Shelly Pinto, the Interim CFO of ALX Oncology Holdings Inc., sold 2,221 shares of the company's common stock on January 6, 2025.
• The sale was executed to satisfy tax obligations arising from the vesting of restricted stock units.
• The shares were sold at a weighted average price of $1.80, with individual transactions ranging from $1.79 to $1.80.
• Following the transaction, Ms. Pinto beneficially owns 87,902 shares of ALX Oncology Holdings Inc.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for company insiders to manage their tax obligations related to equity compensation. It is common for executives to sell shares after vesting to cover taxes.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• The sale of 2,221 shares by the Interim CFO is not unusual for a company of this size and stage.
• The price range of $1.79 to $1.80 is within the expected range for the company's stock.

Stakeholder Impact

• The sale of shares by the Interim CFO may have a minor impact on the stock price, but it is not expected to be significant.

Key Dates

Keywords

ALX Oncology Holdings Inc., Shelly Pinto, Interim CFO, stock sale, tax obligations, restricted stock units, insider trading